Coral calcium claims
This article was originally published in The Tan Sheet
FDA has accepted petition for 26 coral calcium health claims for evaluation, petitioner Marine Bio announces March 4. The Japanese coral calcium firm notes FDA soon will post the claims for a 60-day public comment period. Washington, D.C.-based law firm Emord & Associates filed the claims for Marine Bio in October (1"The Tan Sheet" Oct. 13, 2003, p. 6). Claims sought include "may reduce risk of certain cancers." The FTC has successfully sued coral calcium marketers over false claims, enjoining them from misleading consumers (2"The Tan Sheet" Jan. 26, 2004 p. 10)...
You may also be interested in...
Supplement promoter Robert Barefoot and his companies Deonna Enterprises and Karbo Enterprises have agreed to recall all coral calcium products with packaging, package inserts and labeling that carry unsupported disease claims under a stipulated settlement with the Federal Trade Commission
Coral calcium producer Marine Bio USA is requesting FDA approval of health claims linking calcium with a reduced risk of several diseases including cancers, hypertension and menstrual disorders
Amid a generally harsh environment, venture capital investors in South Korea appeared to take a more selective approach in 2022, with more established and financially stable domestic bioventures the biggest beneficiaries.